{"schema_version":"1","generated_at":"2026-10-29T10:19:13.276Z","data_as_of":null,"url":"https://www.findmykol.com/kol/samuel-ejadi","json_url":"https://www.findmykol.com/kol/samuel-ejadi/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"samuel-ejadi","name":"Samuel Ejadi","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of California, Irvine","institution_url":"https://www.findmykol.com/institution/university-of-california-irvine","city":"Orange","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1285605212","openalex":"A5069836639"},"summary":"Samuel Ejadi is an Oncology physician affiliated with University of California, Irvine. OpenAlex indexes 61 publications with 3,493 citations (h-index 18).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":61,"cited_by_count":3493,"h_index":18,"latest_activity_year":2023,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Amgen Inc.","program_year":2023,"amount_usd":21.52,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1285605212"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1285605212","source":"payments"},"publications":{"total":46,"shown":5,"withheld":41,"matched_by":"OpenAlex author record","recent":[{"title":"A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen","year":2022,"journal":"Medical Oncology","source_url":"https://doi.org/10.1007/s12032-022-01698-9","status":"verified"},{"title":"Histopathologic Evolution of Melanocytes Associated With Rapid Clinical Progression of Melanoma: Clinicopathologic Presentation of Hyperprogressive Disease in a Patient Treated With Immunotherapy","year":2022,"journal":"American Journal of Dermatopathology","source_url":"https://doi.org/10.1097/dad.0000000000002315","status":"verified"},{"title":"A phase Ib multicenter study of trifluridine/tipiracil (FTD/TPI) in combination with irinotecan (IRI) in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma (aGEC) after at least one line of treatment with a fluoropyrimidine and platinum containing regimen.","year":2021,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2021.39.3_suppl.tps251","status":"verified"},{"title":"A phase 1b multicenter study of trifluridine/tipiracil (FTD/TPI) in combination with irinotecan (IRI) in patients (pts) with metastatic or unresectable gastric and gastroesophageal adenocarcinoma (mGEC) after at least one line of treatment with a fluoropyrimidine and platinum (FP) containing regimen.","year":2021,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2021.39.15_suppl.e16006","status":"verified"},{"title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","year":2020,"journal":"British Journal of Cancer","source_url":"https://doi.org/10.1038/s41416-020-0802-1","status":"verified"}],"source":"works"},"contact":{"address_1":"101 THE CITY DR S RM 240","city":"Orange","state":"CA","zip":"928683201","phone":"714-456-8000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1285605212","source":"identity"},"similar":[{"name":"Susan O’Brien","slug":"susan-obrien","institution":"University of California, Irvine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/susan-obrien","json_url":"https://www.findmykol.com/kol/susan-obrien/profile.json"},{"name":"Steven Potkin","slug":"steven-potkin","institution":"University of California, Irvine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/steven-potkin","json_url":"https://www.findmykol.com/kol/steven-potkin/profile.json"},{"name":"Stefan Ciurea","slug":"stefan-ciurea","institution":"University of California, Irvine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stefan-ciurea","json_url":"https://www.findmykol.com/kol/stefan-ciurea/profile.json"},{"name":"Farshid Dayyani","slug":"farshid-dayyani","institution":"University of California, Irvine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/farshid-dayyani","json_url":"https://www.findmykol.com/kol/farshid-dayyani/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":41}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2018-06-06","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}